Please note, there is no save functionality on this form. Please leave adequate time to complete the form.

After submitting the form, please review the form to ensure there are no outstanding fields highlighted in red

Name of proposer:

Email of lead proposer:

Name of co-proposer(s) :

CSG contact (if lead is not a current CSG member):

Meeting or teleconference at which concept was first proposed/discussed:




Is a CTU already involved in the development of the study concept?

If "Yes", which CTU?

please give the name of your CTU contact

It is important to have a CTU on-board during development of study. If you have selected "No", please give some consideration as to who you would like to work with.

For more information, please visit NCRI Cancer CTU Group
►NCRI Cancer CTU Group

Have you considered using data from routine sources collected by the NCRS (National Cancer Registration Service)?

If "Yes", 1) for the planning of the recruitment period and choice of high volume centres?


2) to reduce the burden of data collection:

during the trial?


for longer term follow up?


2. Concept information

Working title:

Brief summary of study design (flow diagram; patient population; main outcome measures; other research opportunities):

Max 500 words

Study diagram:

Please briefly summarise if proposed collaborations are already being explored with:

other NCRI CSGs or groups?

relevant NCIN Site-Specific Clinical Reference Group Chair ?

translational/laboratory groups?

international groups?


3. Please indicate if you are happy for us to initiate discussion in confidence with other NCRI groups:

Cross-cutting CSGs and other Groups :

(if not required, please tick "None")

Site-specific CSGs :

(if not required, please tick "None")

4. International links

Would you like help initiating EORTC or other international collaboration?

For more information on EORTC Collaborative pathways please see:
► Collaboration Pathway UK-Initiated Intergroup Study
► Collaboration Pathway EORTC-Initiated Intergroup Study

Might it be within remit of the International Rare Cancers Initiative (IRCI)?

This information is provided in confidence to the NCRI CSGs Secretariat for use in monitoring advisory group activity and facilitating cross-group collaboration. It is not for release to third parties outside the NCRI and liaison team.

After submitting the form, please review the form to ensure there are no outstanding fields highlighted in red

If you encounter any difficulties submitting your form, please contact us at